A new method of genetic analysis has been devised. The method, amplification refractory mutation system (ARMS), has been used to genotype the J3.11 MspI restriction fragment length polymorphism (RFLP) closely linked to cystic fibrosis (CF). The DNA sequence for both alleles of this dimorphism has been used to design ARMS primers. These allow genotyping of DNA isolated from blood, Guthrie cards, and buccal cells.
The ARMS method allows discrimination of alleles differing by a single base pair using a polymerase chain reaction (PCR) with selectively modified primers.' ARMS does not require DNA of the quantity and quality necessary for conventional filter hybridisation analysis of RFLPs and less than 100 ng of DNA is required.
Purified DNA from peripheral leucocytes and chorionic villus biopsy has been genotyped using ARMS.2 In this report we describe the first use of this method on crude DNA extracts from mouthwash samples and Guthrie cards. These sources of DNA allow non-invasive and retrospective sampling, respectively. A further advantage of ARMS is the avoidance of restriction enzyme cleavage which is subject to problems with incomplete digestion.
The locus detected by the J3. 11 probe is closely linked to CF and contains a dimorphism detected by the restriction enzyme MspI.3 We describe the use of ARMS to determine the J3. 11 MspI RFLP genotype of DNA from the sources described above.
Materials and methods
CHARACTERISATION OF THE J3.11 MspI DIMORPHISM Genomic DNA from a number of healthy volunteers was subjected to PCR amplification using the upstream primer dAAGTTTGAGCATAGG-AAAAGTTCTGTGCCC and the downstream primer dCATCCTTGACTCTTCTCTTTCTCAAAGGCC. These primers flank the dimorphic MspI site. Direct sequence analysis was performed with primer dAGTTCTGTGCCCAAAATTGCATCCAAG, which is nested with respect to the upstream amplification primer, using the method previously described. 4 The sequence characterisation oftheMspl dimorphism is shown in fig 1. .l----l--------.,.I I.
